Table of Contents
What changed
BRM's FY22 result is a wholesale reversal of FY21. Total income (which for this listed investment vehicle is dividend income plus net fair-value movements on the portfolio) swung from a NZD 57.2m inflow to a NZD 32.6m outflow. Profit before tax fell from NZD 51.7m to a NZD 35.2m loss, and NPAT fell from NZD 52.3m to a NZD 34.6m loss. Operating cash flow turned from a NZD 6.7m inflow to a NZD 18.0m outflow. The final dividend was cut to 1.36cps from 1.69cps, a 19.5% reduction. Despite the P&L loss, cash on hand rose modestly to NZD 2.6m from NZD 0.9m. Total equity contracted 8.1% to NZD 170.7m, consistent with a mark-to-market-driven NAV decline rather than a cash burn.
What matters
- Second-half deterioration dominates. HY22 was already weak (NPAT NZD 14.9m, revenue NZD 17.3m), but the implied second half shows revenue of roughly –NZD 49.9m and NPAT of roughly –NZD 49.6m. The full-year loss is essentially a H2 event driven by portfolio re-pricing.
- The loss is almost entirely unrealised portfolio value. With FY21 dividend income of NZD 2.8m (a reasonable proxy for the cash yield of the book), the NZD 89.8m year-on-year income swing is overwhelmingly fair-value movement, not a change in the cash-yielding capacity of the portfolio.
- Capital allocation has already been tightened. The 19.5% cut to the final dividend, alongside a ROE swing from +28.2% to –20.3%, signals the board is sizing distributions against a smaller equity base.
Expectations
No forward earnings guidance, forward-work book or stated NAV target was disclosed in the extracted materials, so there is no management benchmark to test the result against. The H1-to-H2 shape (H1 contributing a positive NZD 14.9m to NPAT, full year –NZD 34.6m) is the clearest context point: it indicates that the majority of the damage occurred in the second half and that any read on FY23 depends on subsequent market moves rather than on an operating trend disclosed here. The release supports the conclusion that FY22 was a mark-to-market loss year; it does not support any inference about portfolio recovery post-balance-date.
Quality of result
As a listed investment company, BRM's "earnings" are structurally dominated by fair-value accounting. Two observations follow:
- The cash yield of the book remains small relative to headline earnings. On FY21 disclosure, dividend income was NZD 2.8m against NPAT of NZD 52.3m — i.e. cash income is an order of magnitude smaller than the P&L line, and the same asymmetry now works in reverse.
- Operating cash flow of –NZD 18.0m is a genuine deterioration versus +NZD 6.7m, and cash conversion has clearly weakened. However, the operating cash line in a closed-end investment vehicle reflects purchases and sales of investments and dividends received, not trading profitability, so it should not be read as a business-model-quality indicator in the same way as for an operating company.
The underlying portfolio contracted in value; there is no evidence of timing or working-capital assistance inflating or deflating the reported number. The result is durable in the sense that it reflects observable NAV, and low-quality only in the sense that it is market-driven rather than earned.
Unresolved
- What is the composition of the fair-value loss by sector or position, and how much was realised versus unrealised?
- Is the –NZD 18.0m operating cash flow a function of net investment activity (portfolio turnover) or of reduced dividend receipts, and what is the sustainable cash-yield run-rate of the current book?
- What is the NTA per share at balance date and the discount/premium at which the listed shares trade relative to it? Valuation ratios are not computable from the supplied data.
- With total liabilities of just NZD 1.7m and no disclosed borrowings, is the vehicle now considering any form of gearing or buyback, and what is the dividend policy going forward given ROE has turned negative?
This briefing cannot assess post-balance-date NAV movement, portfolio composition, or how BRM's share price discount to NTA has evolved alongside the reported loss.
Key metrics
| Metric | FY22 | FY21 | Change |
|---|---|---|---|
| Revenue | −$32.6m | $57.2m | -157.0% ↓ |
| Net profit after tax | −$34.6m | $52.3m | -166.2% ↓ |
| Net cash inflow from operating activities | −$18.0m | $6.7m | -369.7% ↓ |
| Final dividend per share | 1.4c | 1.7c | -19.5% ↓ |
| Operating profit | −$35.2m | $51.7m | -168.0% ↓ |
| Profit before tax | −$35.2m | $51.7m | -168.0% ↓ |
| Cash and cash equivalents | $2.6m | $0.9m | +171.4% ↑ |
| Total assets | $172.3m | $188.5m | -8.6% ↓ |
Reference: annolyse.ai/briefings/brm-fy22
Analytical metrics
| Metric | FY22 | FY21 | Context |
|---|---|---|---|
| Effective tax rate | n/m (loss period) | 1.2% | current loss period |
| Trade debtors | — | $0.0m | — |
| Payout ratio vs NPAT | -9.7% | — | — |
| ROE (annualised) | -20.3% | 28.2% | Weakening |
| HY22 share of FY22 revenue | -53.0% | — | Other half was 153.0% |
| HY22 share of FY22 NPAT | -43.1% | — | Other half was 143.1% |
| Profit from continuing operations | −$34.6m | $52.3m | −$87.0m |
Reference: annolyse.ai/briefings/brm-fy22
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.